Your search:
107 result(s) in 0.06 s
-
DUKAS_188853670_NUR
Lagos State, Partners Review Pathway To Malaria Pre-Elimination And Digitalization Programme
Participants watch slides as the Lagos State Government, in conjunction with its partners, holds a mid-term review of the Pathway to Malaria Pre-Elimination and Digitization Programme, an approach that leverages technology, partnerships, and community providers to transform malaria service at scale, in Lagos State, Nigeria, on September 11, 2024, at Eko Hotel, Victoria Island. The programme is implemented under the Immunisation Plus and Malaria Progress by Accelerating Coverage and Transforming Services (IMPACT) Project, a World Bank-supported initiative implemented by the Lagos State Ministry of Health in collaboration with national and global partners. (Photo by Adekunle Ajayi/NurPhoto) -
DUKAS_188853617_NUR
Lagos State, Partners Review Pathway To Malaria Pre-Elimination And Digitalization Programme
Participants watch slides as the Lagos State Government, in conjunction with its partners, holds a mid-term review of the Pathway to Malaria Pre-Elimination and Digitization Programme, an approach that leverages technology, partnerships, and community providers to transform malaria service at scale, in Lagos State, Nigeria, on September 11, 2024, at Eko Hotel, Victoria Island. The programme is implemented under the Immunisation Plus and Malaria Progress by Accelerating Coverage and Transforming Services (IMPACT) Project, a World Bank-supported initiative implemented by the Lagos State Ministry of Health in collaboration with national and global partners. (Photo by Adekunle Ajayi/NurPhoto) -
DUKAS_188853602_NUR
Lagos State, Partners Review Pathway To Malaria Pre-Elimination And Digitalization Programme
Participants watch slides as the Lagos State Government, in conjunction with its partners, holds a mid-term review of the Pathway to Malaria Pre-Elimination and Digitization Programme, an approach that leverages technology, partnerships, and community providers to transform malaria service at scale, in Lagos State, Nigeria, on September 11, 2024, at Eko Hotel, Victoria Island. The programme is implemented under the Immunisation Plus and Malaria Progress by Accelerating Coverage and Transforming Services (IMPACT) Project, a World Bank-supported initiative implemented by the Lagos State Ministry of Health in collaboration with national and global partners. (Photo by Adekunle Ajayi/NurPhoto) -
DUKAS_188853595_NUR
Lagos State, Partners Review Pathway To Malaria Pre-Elimination And Digitalization Programme
Babajide Sanwo-Olu, Governor of Lagos State, speaks as the Lagos State Government, in conjunction with its partners, holds a mid-term review of the Pathway to Malaria Pre-Elimination and Digitization Programme, an approach that leverages technology, partnerships, and community providers to transform malaria service at scale, in Lagos State, at Eko Hotel, Victoria Island, Lagos State, Nigeria, on September 11, 2024. The programme is implemented under the Immunisation Plus and Malaria Progress by Accelerating Coverage and Transforming Services (IMPACT) Project, a World Bank-supported initiative implemented by the Lagos State Ministry of Health in collaboration with national and global partners. (Photo by Adekunle Ajayi/NurPhoto) -
DUKAS_188853593_NUR
Lagos State, Partners Review Pathway To Malaria Pre-Elimination And Digitalization Programme
Babajide Sanwo-Olu, Governor of Lagos State, speaks as the Lagos State Government, in conjunction with its partners, holds a mid-term review of the Pathway to Malaria Pre-Elimination and Digitization Programme, an approach that leverages technology, partnerships, and community providers to transform malaria service at scale, in Lagos State, at Eko Hotel, Victoria Island, Lagos State, Nigeria, on September 11, 2024. The programme is implemented under the Immunisation Plus and Malaria Progress by Accelerating Coverage and Transforming Services (IMPACT) Project, a World Bank-supported initiative implemented by the Lagos State Ministry of Health in collaboration with national and global partners. (Photo by Adekunle Ajayi/NurPhoto) -
DUKAS_188853592_NUR
Lagos State, Partners Review Pathway To Malaria Pre-Elimination And Digitalization Programme
Babajide Sanwo-Olu, Governor of Lagos State, speaks as the Lagos State Government, in conjunction with its partners, holds a mid-term review of the Pathway to Malaria Pre-Elimination and Digitization Programme, an approach that leverages technology, partnerships, and community providers to transform malaria service at scale, in Lagos State, at Eko Hotel, Victoria Island, Lagos State, Nigeria, on September 11, 2024. The programme is implemented under the Immunisation Plus and Malaria Progress by Accelerating Coverage and Transforming Services (IMPACT) Project, a World Bank-supported initiative implemented by the Lagos State Ministry of Health in collaboration with national and global partners. (Photo by Adekunle Ajayi/NurPhoto) -
DUKAS_188853572_NUR
Lagos State, Partners Review Pathway To Malaria Pre-Elimination And Digitalization Programme
Prof. Akin Abayomi, Commissioner for Health Lagos State, makes a presentation as the Lagos State Government, in conjunction with its partners, holds a mid-term review of the Pathway to Malaria Pre-Elimination and Digitization Programme, an approach that leverages technology, partnerships, and community providers to transform malaria service at scale, in Lagos State, at Eko Hotel, Victoria Island, Lagos State, Nigeria, on September 11, 2024. The programme is implemented under the Immunisation Plus and Malaria Progress by Accelerating Coverage and Transforming Services (IMPACT) Project, a World Bank-supported initiative implemented by the Lagos State Ministry of Health in collaboration with national and global partners. (Photo by Adekunle Ajayi/NurPhoto) -
DUKAS_188853563_NUR
Lagos State, Partners Review Pathway To Malaria Pre-Elimination And Digitalization Programme
Prof. Akin Abayomi, Commissioner for Health Lagos State, looks on as the Lagos State Government, in conjunction with its partners, holds a mid-term review of the Pathway to Malaria Pre-Elimination and Digitization Programme. This approach leverages technology, partnerships, and community providers to transform malaria service at scale in the state. The event takes place at Eko Hotel, Victoria Island, Lagos State, Nigeria, on September 11, 2024. The programme is implemented under the Immunisation Plus and Malaria Progress by Accelerating Coverage and Transforming Services (IMPACT) Project, a World Bank-supported initiative implemented by the Lagos State Ministry of Health in collaboration with national and global partners. (Photo by Adekunle Ajayi/NurPhoto) -
DUKAS_188853561_NUR
Lagos State, Partners Review Pathway To Malaria Pre-Elimination And Digitalization Programme
Ibrahim Yakasai, Chairman of Maisha Meds Nigeria, speaks as the Lagos State Government, in conjunction with its partners, holds a mid-term review of the Pathway to Malaria Pre-Elimination and Digitization Programme. This approach leverages technology, partnerships, and community providers to transform malaria service at scale in the state, at Eko Hotel, Victoria Island, Lagos State, Nigeria, on September 11, 2024. The programme is implemented under the Immunisation Plus and Malaria Progress by Accelerating Coverage and Transforming Services (IMPACT) Project, a World Bank-supported initiative implemented by the Lagos State Ministry of Health in collaboration with national and global partners. (Photo by Adekunle Ajayi/NurPhoto) -
DUKAS_188853556_NUR
Lagos State, Partners Review Pathway To Malaria Pre-Elimination And Digitalization Programme
Dr. Jessica Vernon, Chief Executive Officer of Maisha Meds, makes a presentation as the Lagos State Government, in conjunction with its partners, holds a mid-term review of the Pathway to Malaria Pre-Elimination and Digitization Programme. This approach leverages technology, partnerships, and community providers to transform malaria service at scale in the state. The event takes place at Eko Hotel, Victoria Island, Lagos State, Nigeria, on September 11, 2024. The programme is implemented under the Immunisation Plus and Malaria Progress by Accelerating Coverage and Transforming Services (IMPACT) Project, a World Bank-supported initiative implemented by the Lagos State Ministry of Health in collaboration with national and global partners. (Photo by Adekunle Ajayi/NurPhoto) -
DUKAS_188853544_NUR
Lagos State, Partners Review Pathway To Malaria Pre-Elimination And Digitalization Programme
Babajide Sanwo-Olu, Governor of Lagos State, speaks as the Lagos State Government, in conjunction with its partners, holds a mid-term review of the Pathway to Malaria Pre-Elimination and Digitization Programme, an approach that leverages technology, partnerships, and community providers to transform malaria service at scale, in Lagos State, at Eko Hotel, Victoria Island, Lagos State, Nigeria, on September 11, 2024. The programme is implemented under the Immunisation Plus and Malaria Progress by Accelerating Coverage and Transforming Services (IMPACT) Project, a World Bank-supported initiative implemented by the Lagos State Ministry of Health in collaboration with national and global partners. (Photo by Adekunle Ajayi/NurPhoto) -
DUKAS_188853543_NUR
Lagos State, Partners Review Pathway To Malaria Pre-Elimination And Digitalization Programme
Babajide Sanwo-Olu, Governor of Lagos State, speaks as the Lagos State Government, in conjunction with its partners, holds a mid-term review of the Pathway to Malaria Pre-Elimination and Digitization Programme, an approach that leverages technology, partnerships, and community providers to transform malaria service at scale, in Lagos State, at Eko Hotel, Victoria Island, Lagos State, Nigeria, on September 11, 2024. The programme is implemented under the Immunisation Plus and Malaria Progress by Accelerating Coverage and Transforming Services (IMPACT) Project, a World Bank-supported initiative implemented by the Lagos State Ministry of Health in collaboration with national and global partners. (Photo by Adekunle Ajayi/NurPhoto) -
DUKAS_188853541_NUR
Lagos State, Partners Review Pathway To Malaria Pre-Elimination And Digitalization Programme
Dr. Jessica Vernon, Chief Executive Officer of Maisha Meds, makes a presentation as the Lagos State Government, in conjunction with its partners, holds a mid-term review of the Pathway to Malaria Pre-Elimination and Digitization Programme. This approach leverages technology, partnerships, and community providers to transform malaria service at scale in the state. The event takes place at Eko Hotel, Victoria Island, Lagos State, Nigeria, on September 11, 2024. The programme is implemented under the Immunisation Plus and Malaria Progress by Accelerating Coverage and Transforming Services (IMPACT) Project, a World Bank-supported initiative implemented by the Lagos State Ministry of Health in collaboration with national and global partners. (Photo by Adekunle Ajayi/NurPhoto) -
DUKAS_187235518_FER
dukas 187235518 fer
Ferrari Press Agency
Malaria 1
Ref 17021
24/07/2025
See Ferrari text
Picture MUST credit: Zhiqian Li, Bier Lab, UC San Diego
A new method that genetically blocks mosquitoes from transmitting malaria has been developed by researchers.
The flying insects are responsible for the deaths of more people each year than any other animal.
In 2023, the blood-sucking bugs infected a reported 263 million people with malaria, leading to nearly 600,000 deaths, 80 percent of them children.
Now, a US team drawn from the University of California San Diego, Johns Hopkins University, UC Berkeley and the University of São Paulo have created a gene-editing system that changes a single molecule within mosquitoes.
This minuscule but effective change stops the malaria-parasite transmission process.
Genetically altered mosquitoes are still able to bite those with malaria and acquire parasites from their blood, but the parasites can no longer be spread to other people.
The new system is designed to genetically spread the malaria resistance trait until entire populations of the insects no longer transfer the disease-causing parasites.
OPS: Genetically modified mosquito larvae express fluorescent markers of the FREP1 gene — RFP (pink), GFP (blue) or both (yellow) — to indicate whether they spread or block infection from malarial parasites.
P{icture supplied by Ferrari (FOTO: DUKAS/FERRARI PRESS) -
DUKAS_185900472_EYE
GM mosquitoes: inside the lab breeding six-legged agents in the war on malaria.
GM mosquitoes: inside the lab breeding six-legged agents in the war on malaria.
A British company is producing mosquitoes that carry a 'self-limiting' gene that kills off female offspring, limiting the spread of diseases such as malaria and dengue fever.
Oxitec Team leader Anna Schoenaver studying mosquito lavae and pupae of mosquitos that have the 'Friendly gene', at the companies laboratories in Oxfordshire.
"OxitecÕs Friendlyª mosquito technology uses two simple genes that create safe, non-biting, self-limiting and non-persistent male mosquitoes. OxitecÕs technology is safe for humans, animals and the environment, and targets only target disease vector species." [Taken from OXITEC website].
2/4/25.
Tom Pilston / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
Tom Pilston tompilston.com tompilston@gmail.com -
DUKAS_185900461_EYE
GM mosquitoes: inside the lab breeding six-legged agents in the war on malaria.
GM mosquitoes: inside the lab breeding six-legged agents in the war on malaria.
A British company is producing mosquitoes that carry a 'self-limiting' gene that kills off female offspring, limiting the spread of diseases such as malaria and dengue fever.
Oxitec Team leader Anna Schoenaver studying mosquito lavae and pupae of mosquitos that have the 'Friendly gene', at the companies laboratories in Oxfordshire.
"OxitecÕs Friendlyª mosquito technology uses two simple genes that create safe, non-biting, self-limiting and non-persistent male mosquitoes. OxitecÕs technology is safe for humans, animals and the environment, and targets only target disease vector species." [Taken from OXITEC website].
2/4/25.
Tom Pilston / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
Tom Pilston tompilston.com tompilston@gmail.com -
DUKAS_185900471_EYE
GM mosquitoes: inside the lab breeding six-legged agents in the war on malaria.
GM mosquitoes: inside the lab breeding six-legged agents in the war on malaria.
A British company is producing mosquitoes that carry a 'self-limiting' gene that kills off female offspring, limiting the spread of diseases such as malaria and dengue fever.
Michal Bilski, RND team leader at Oxitec, works on inserting genes into mosquito eggs to create 'Friendly Mosquitos' at the companies laboratories in Oxfordshire.
"OxitecÕs Friendlyª mosquito technology uses two simple genes that create safe, non-biting, self-limiting and non-persistent male mosquitoes. OxitecÕs technology is safe for humans, animals and the environment, and targets only target disease vector species." [Taken from OXITEC website].
2/4/25.
Tom Pilston / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
Tom Pilston tompilston.com tompilston@gmail.com -
DUKAS_185900463_EYE
GM mosquitoes: inside the lab breeding six-legged agents in the war on malaria.
GM mosquitoes: inside the lab breeding six-legged agents in the war on malaria.
A British company is producing mosquitoes that carry a 'self-limiting' gene that kills off female offspring, limiting the spread of diseases such as malaria and dengue fever.
Michal Bilski, RND team leader at Oxitec, works on inserting genes into mosquito eggs to create 'Friendly Mosquitos' at the companies laboratories in Oxfordshire. Shot through to microscope the injection needle cna be seen about to administer the genes.
"OxitecÕs Friendlyª mosquito technology uses two simple genes that create safe, non-biting, self-limiting and non-persistent male mosquitoes. OxitecÕs technology is safe for humans, animals and the environment, and targets only target disease vector species." [Taken from OXITEC website].
2/4/25.
Tom Pilston / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
Tom Pilston tompilston.com tompilston@gmail.com -
DUKAS_147028194_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Kenyan scientifics work in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028209_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Kenyan scientifics work in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028230_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A scientific works in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028206_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A scientific works in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028207_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A scientific works registering some samples in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028208_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A scientific works in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028231_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A scientific works in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028193_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A scientific works in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028190_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A scientific works in the immunology and microbiology labs at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028191_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Vaccinologist George Warimwe poses for a portrait at KEMRI-Wellcome Trust laboratories in Kilifi, Kenya on May 20, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028253_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother explains her son symptoms to some nurses during a medical checkups in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028192_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Mothers wait with their babies for medical checkups in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028188_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother holds her daughter in front of some nurses during a medical checkups in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028205_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Annah Kadhengi holds her son Brighton Ushindi Baraka -who suffered malaria- in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028229_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother waits with her daughter for a medical checkups in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028228_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother waits with her daughter for a medical checkups in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028183_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Mothers wait with their babies for medical checkups in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028187_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Mothers wait with their babies for medical checkups in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028226_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother holding her child gets registered in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028202_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Parents wait with their babies for medical checkups in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028225_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A nurse calls a mother and her baby to be checked in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028186_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother holding her child gets registered in the maternal child ward at Kilifi County Hospital in Kilifi, Kenya on May 20, 2022. Many parents come to the hospital with kids suffering malaria symptoms and will get tested for the disease and referred to a specialist.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory in Kilifi has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028203_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A boy walks from school towards his house in Junju, Kilifi County, Kenya on May 19, 2022. The morphology of the terrain and the weather patterns -tropical humid- are a perfect environment for malaria to spread, making this area of Kenya a malaria-endemic region.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028199_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A valley is seen in Junju, Kilifi County, Kenya on May 19, 2022. The morphology of the terrain and the weather patterns -tropical humid- are a perfect environment for malaria to spread, making this area of Kenya a malaria-endemic region.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028227_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Scattered houses are seen in a village in Junju, Kilifi County, Kenya on May 19, 2022. The morphology of the terrain and the weather patterns -tropical humid- are a perfect environment for malaria to spread, making this area of Kenya a malaria-endemic region.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028223_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
Kenyan mothers hold their children at a waiting area while expecting to get attended for medical checkups at Junju Dispensary KEMRI wing in Junju, Kilifi County, Kenya on May 19, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028200_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother covers holds her son -who took part in the malaria vaccine trial- while two community health extract some blood samples to be analyzed during a medical checkup at Junju Dispensary KEMRI wing in Junju, Kilifi County, Kenya on May 19, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028198_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother covers hers and her young daughter’s faces -who took part in the malaria vaccine trial- while two community health extract some blood samples to be analyzed during a medical checkup at Junju Dispensary KEMRI wing in Junju, Kilifi County, Kenya on May 19, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028181_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
32-year-old Khadijah Mcharo Kapitao holds her sleeping daughter -who tested positive for malaria recently- while expecting to get attended for medical checkups in the waiting area at Junju Dispensary KEMRI wing in Junju, Kilifi County, Kenya on May 19, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028180_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A mother holds her young daughter -who took part in the malaria vaccine trial- who is asleep while two community health gets to extract some blood samples to be analyzed during a medical checkup at Junju Dispensary KEMRI wing in Junju, Kilifi County, Kenya on May 19, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028196_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A community health worker checks on Mama Raheli’s son -who was part of the malaria vaccine trial- during a medical checkup at Junju Dispensary KEMRI wing in Junju, Kilifi County, Kenya on May 19, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_147028222_EYE
New malaria vaccine comes a step closer as experts say it’s ‘the best yet’.
A community health worker checks the pulse of Mama Raheli’s son -who was part of the malaria vaccine trial- during a medical checkup at Junju Dispensary KEMRI wing in Junju, Kilifi County, Kenya on May 19, 2022.
Malaria kills 260,000 children under five in sub-Saharan Africa every year. Promising results from a recent vaccine trial in Kenya has raised new hope in the fight against malaria.
The phase II clinical trial was conducted at the Kenya Medical Research Institute (KEMRI) field located in Junju, Kilifi County Kenya. KEMRI-Wellcome Trust laboratory has been actively working in collaboration with other labs around the world in the development of a safe and effective malaria vaccine.
Photo: Luis Tato for The Guardian
© Luis Tato / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
